Hemoglobin based oxygen carriers: How much methemoglobin is too much?

被引:79
作者
Linberg, R [1 ]
Conover, CD [1 ]
Shum, KL [1 ]
Shorr, RGL [1 ]
机构
[1] Enzon Inc, Res & Dev, Formulat Toxicol Dept, Piscataway, NJ 08854 USA
来源
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY | 1998年 / 26卷 / 02期
关键词
D O I
10.3109/10731199809119772
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The oxidized form of hemoglobin, methemoglobin, is unable to deliver oxygen to tissues. Hemoglobin based oxygen carriers generally lack the natural oxidative-reductive machinery present within the red blood cell that converts methemoglobin to hemoglobin. This study examines tolerable levels of methemoglobin that can be present in solutions of polyethylene glycol (PEG) conjugated bovine hemoglobin without compromising its ability to deliver oxygen. Rodents were exchange-transfused to 30% of their estimated blood volume with solutions of six grams percent PEG-hemoglobin containing varying concentrations of, PEG-methemoglobin. Tissue oxygenation was measured by an oxygen dependant phosphorescence quenching method. This study also looked at the level of methemoglobin formation following a top loaded infusion of low methemoglobin containing PEG-hemoglobin. Results of the oxygenation study showed that PEG-methemoglobin levels at or below 10% did not significantly alter the ability of solutions to deliver oxygen to intestines, liver, spleen and kidney. However, PEG-methemoglobin levels greater than 10% resulted in a significant decrease in PEG-hemoglobin's ability to oxygenate tissues. In addition, methemoglobin levels remain low (< 10%) for a substantial period of time following PEG-hemoglobin administration.
引用
收藏
页码:133 / 148
页数:16
相关论文
共 47 条
[1]   HEMOGLOBIN COVALENTLY BRIDGED ACROSS POLYPHOSPHATE BINDING-SITE [J].
BENESCH, R ;
BENESCH, RE ;
YUNG, S ;
EDALJI, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1975, 63 (04) :1123-1129
[2]   BIS-PYRIDOXAL POLYPHOSPHATES - A NEW CLASS OF SPECIFIC INTRAMOLECULAR CROSSLINKING AGENTS FOR HEMOGLOBIN [J].
BENESCH, RE ;
KWONG, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 156 (01) :9-14
[4]  
CHATTERJEE R, 1986, J BIOL CHEM, V261, P9929
[5]  
CONOVER C, 1997, IN PRESS ART ORGANS
[6]  
Conover CD, 1996, J INVEST MED, V44, P238
[7]   INTRAVASCULAR REDUCTION OF METHEMOGLOBIN IN PLASMA OF THE RAT INVIVO [J].
DENBOER, PJ ;
BLEEKER, WK ;
RIGTER, G ;
AGTERBERG, J ;
STEKKINGER, P ;
KANNEGIETER, LM ;
DENIJS, IMM ;
BAKKER, JC .
BIOMATERIALS ARTIFICIAL CELLS AND IMMOBILIZATION BIOTECHNOLOGY, 1992, 20 (2-4) :647-650
[8]   Blood substitutes: Fluids, drugs, or miracle solutions? [J].
Dietz, NM ;
Joyner, MJ ;
Warner, MA .
ANESTHESIA AND ANALGESIA, 1996, 82 (02) :390-405
[9]  
ESTEP TN, 1989, BLOOD SUBSTITUTES
[10]  
FEOLA M, 1983, SURG GYNECOL OBSTET, V157, P399